Investigation of the Relationship of Vitamin D, Parathyroid Hormone, Calcium Serum Level, and Insulin Resistance among Obese Individuals

Hadeel Al-Khalidi; Abuzer Çelekli; Zeynel Abidin Sayıner; Mustafa Araz

doi:10.5152/EurJTher.2018.507

Authors

Hadeel Al-Khalidi Department of Biochemistry Science and Technology, Gaziantep University, Institute of Natural and Applied Sciences, Gaziantep https://orcid.org/0000-0001-6954-7387
Abuzer Çelekli Department of Biochemistry Science and Technology, Gaziantep University, Institute of Natural and Applied Sciences, Gaziantep https://orcid.org/0000-0002-2448-4957
Zeynel Abidin Sayıner Department of Endocrinology and Metabolic Diseases, Gaziantep University School of Medicine, Gaziantep https://orcid.org/0000-0001-5105-0292
Mustafa Araz Department of Endocrinology and Metabolic Diseases, Gaziantep University School of Medicine, Gaziantep https://orcid.org/0000-0001-6741-7474

DOI:

https://doi.org/10.5152/EurJTher.2018.507

Keywords:

Calcium, insulin resistance, obesity, parathormone, vitamin D

Abstract

Objective: Several studies have shown that 25-hydroxyvitamin D, parathyroid hormone (PTH), and serum calcium (Ca) may play functional roles with insulin resistance.
Methods: This case–control study included 60 obese individuals with impaired fasting glucose who were compared with 60 nonobese individuals with normal fasting glucose who visited the endocrinology and metabolism department. Fasting plasma glucose, fasting insulin, triglyceride, PTH, and serum 25-hydroxyvitamin D (25(OH)D) were measured from all subjects in the morning after approximately 8 h of fasting using methods with respect to the standard operating procedures. Homeostatic model assessment of insulin resistance (HOMA-IR) was used for determining insulin resistance. The statistical analysis was attained by SPSS.
Results: A lack of association was found between serum 25(OH)D and insulin resistance (HOMA-IR) before and after adjusting PTH, Ca, and various variables either in all participants or after exclusion of participants with HOMA-IR ≤2.5. On the other hand, PTH showed a significant inverse correlation with fasting insulin (p=0.022) and HOMA-IR (p=0.023) after adjusting 25(OH)D, serum Ca, and various variables and exclusion of participants with HOMA-IR ≤2.5.
Conclusion: In the present study, we did not find a relationship between insulin resistance and vitamin D levels. Further studies are needed for clarifying the relationship between insulin resistance and vitamin D levels.

Metrics

Metrics Loading ...

References

Silver J, Naveh-Many T. Vitamin D and the parathyroid. In Vitamin D, edn 2, Eds D Feldman, F Glorieux & J Wesley Pike. San Diego, Elsevier, 2004.

Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501.

Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol 1994; 267: E356-60.

Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001; 24: 1496.

Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njølstad I, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromso Study 1994- 95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 2010; 27: 1107-15.

Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813-8.

Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle aged and elderly Chinese individuals. Diabetes Care 2009; 32: 1278-83.

Chiu KC, Chuang LM, Lee NP, Ryu JM, McGullam JL, Tsai GP, et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 2000; 49: 1501-5.

Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, et al. Prevalence of metabolic syndrome in the general japanese population in 2000. J Atheroscler Thromb 2006; 13: 202-8.

Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J, et al. Vitamin D-3 in fat tissue. Endocr J 2008; 33: 90-4.

Hedbeack G, Odaen A. Increased risk of death from primary hyperparathyroidism-an update. Eur J Clin Invest 1998; 28: 271-6.

Howard G, O’Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996; 93: 1809-17.

Tremblay A, Gilbert JA. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 2009; 28: 91-102.

Zemel MB. Nutritional and endocrine modulation of intracellularcalcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem 1998; 188: 129-36.